Development asset linked to REVELATION BIOSCIENCES in public FDA and regional records.
pharma · Renal Insufficiency, Chronic · REVB
REVELATION BIOSCIENCES
REVELATION BIOSCIENCES, INC.
REVELATION BIOSCIENCES drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
San Diego, USA HQ
2020 Founded
14 Employees
Public company Type
REVB · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2020
- Employees
- 14
- Programs
- 1
- Drugs
- 1
- Patents
- 2
REVELATION BIOSCIENCES pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
REVELATION BIOSCIENCES drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.